- Publication
- Apr 29, 2022
Intense bitterness of molecules: Machine learning for expediting drug discovery
Eitan Margulis, et al. Computational and Structural Biotechnology Journal, 2021, 19, 568-576- Publication
- Sep 8, 2015
Search for Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Using Chemical Similarity, Molecular Docking, and MM-GB/SA Scoring
Barreiro, et al. J. Chem. Inf. Model., 2007, 47, 2416-2428- Publication
- Sep 8, 2015
Dihydropyridopyrazinones and Dihydropteridinones as Corticotropin-Releasing Factor-1 Receptor Antagonists: Structure-Activity Relationships and Computational Modeling
Dzierba, et al. J. Med. Chem., 2007, 50, 2269-2272- Publication
- Sep 8, 2015
Computer-Aided Design of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
Jorgensen, et al. Bioorg. Med. Chem. Lett., 2006, 16, 663-667- Publication
- Sep 8, 2015
Solution-Phase Synthesis of a Tricyclic Pyrrole-2-Carboxamide Discovery Library Applying a Stetter-Paal-Knorr Reaction Sequence
Werner, et al. J. Comb. Chem., 2006, 8, 368-380- Publication
- Sep 8, 2015
Inluence of Molecular Flexibility and Polar Surface Area Metrics on Oral Bioavailability in the Rat
Lu, et al. J. Med. Chem., 2004, 47, 6104-6107- Publication
- Sep 8, 2015
QSAR Studies of PC-3 Cell Line Inhibition Activity of TSA and SAHA-like Hydroxamic Acids
Wang, et al. Bioorg. Med. Chem. Lett., 2004, 14, 707-711- Publication
- Sep 8, 2015
Prediction of in vitro metabolic stability of calcitriol analogs by QSAR
Jensen, et al. J. Comput. Aided Mol. Des., 2003, 17, 849-859- Publication
- Sep 8, 2015
Prediction of Drug Solubility from Structure
Jorgensen, et al. Adv. Drug Deliv. Rev., 2002, 54, 355-366- Publication
- Sep 8, 2015
Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water
Duffy, et al. J. Am. Chem. Soc., 2000, 122, 2878-88- Publication
- Sep 8, 2015
A Structure-Based Model for Predicting Serum Albumin Binding
Lexa, et al. PLoS ONE, 2014, 9(4), e93323- Publication
- Sep 8, 2015
Discovery of Thienoquinolone Derivatives as Selective and ATP Non-Competitive CDK5/p25 Inhibitors by Structure-Based Virtual Screening
Chatterjee, et al. Bioorg. Med. Chem., 2014, 22, 6409-6421
Latest insights from Extrapolations blog
With FEP+, “The Experiment is the Limit.”
Over the past century, small molecule drugs have represented the dominant modality in drug research, enabling medical breakthroughs that have saved countless lives.
Tackling Drug Solubility: AbbVie and Schrödinger Collaborate to Advance Accurate Prediction Methods
The complexity and size of drug candidates has grown in recent years as scientists pursue novel targets once considered undruggable.
Blog
Can AlphaFold Models be Used for Structure-Based Drug Design? A Perspective Two Years In
We recently sat down with Edward Miller, Senior Director of Protein Structure Modeling at Schrödinger, to discuss his experience using AlphaFold models for SBDD.
Training & Resources
Online certification courses
Level up your skill set with hands-on, online molecular modeling courses. These self-paced courses cover a range of scientific topics and include access to Schrödinger software and support.
Free learning resources
Learn how to deploy the technology and best practices of Schrödinger software for your project success. Find training resources, tutorials, quick start guides, videos, and more.
Other Resources